Public anxiety around hantavirus often spikes whenever unusual respiratory symptoms make headlines. The clinical presentation of HPS differs profoundly from endemic viral infections like influenza or COVID-19, both in speed and lethality.
| Diagnostic Metric | Hantavirus Pulmonary Syndrome (HPS) | COVID-19 (Omicron & Descendant Strains) |
|---|---|---|
| Primary Transmission Vector | Aerosolized rodent droppings, urine, or saliva | Human-to-human respiratory droplets |
| Estimated Mortality Rate | 35%, 40% case fatality rate | Under 0.5% in broad populations |
| Incubation Window | 1, 8 weeks after rodent exposure | 2, 5 days post-exposure |
| Annual US Caseload | Rare (20, 40 confirmed cases annually) | Millions of seasonal infections |
| Hallmark Clinical Sign | Sudden, rapid non-cardiogenic pulmonary edema | Upper respiratory congestion, fever, dry cough |
